Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Erythromycin, Mitemcinal and related antibiotics act as non-peptide motilin agonists, and are sometimes used for their ability to stimulate gastrointestinal motility. In the case of erythromycin, it is its hemiketal intermediate, formed after an oral dose in the low-pH environment of the stomach lumen, which directly acts on the motilin receptor. Administration of a low dose of erythromycin will induce peristalsis, which provides additional support for the conclusion that motilin secretion triggers this pattern of gastrointestinal motility, rather than results from it. However, some of erythromycin's properties, including antibiotic activity, are not appropriate for a drug designed for chronic use over a patient's lifetime. New motilin agonists are erythromycin-based; however, it may be that this class of drugs becomes redundant. Growth hormone secretagogue receptors share 52% of their DNA with motilin receptors, and agonists of these receptors, termed ghrelins, can bring about similar effects to motilin agonists. Camicinal is a motilin agonist under development. Xylitol ingestion also increases motilin secretion, which may be related to xylitol's ability to cause diarrhea.
226Ra occurs in the decay chain of uranium-238 (238U), which is the most common naturally occurring isotope of uranium. It undergoes alpha decay to radon-222, which is also radioactive; the decay chain ultimately terminates at lead-206. Because of its occurrence in the 238U decay chain, 226Ra exists naturally at low concentrations not only in uranium-containing minerals, but universally diffused in the environment (as also is uranium), as in soil and groundwater.
1 by the Secretary of State for Home Affairs 1 by the Minister for Transport 6 by the London County Council: 1 by the Corporation of the City of London: 1 by the Council of the City of Westminster: 6 by the councils of the remaining metropolitan boroughs: 2 by the Middlesex County Council: 1 by Essex County Council: 1 by the Kent County Council: 1 by the Surrey County Council: 1 by the Buckinghamshire and Hertfordshire County Councils: 1 by the Council of the County Borough of Croydon: 1 by the Council of the County Borough of East Ham: 1 by the Council of the County Borough of West Ham: 1 by the Secretary of State to represent the metropolitan police: 1 by the Secretary of State to represent county and borough police forces in the London Traffic Area: 1 by the Corporation of the City of London to represent the City police: 4 by the British Transport Commission: 5 by the Minister of Labour, after consultation with such bodies representative of those interests as he may think fit, to represent the interests of labour engaged in the transport industry within the London Traffic Area: 2 by the Minister, after consultation with such bodies representative of those interests as he may think fit, to represent the interests of persons (other than such persons as are hereinafter mentioned and other than the British Transport Commission and any Executive) providing or using mechanically propelled road vehicles within the London Traffic Area.
Sources: en.wikipedia.org
In fact, the aggregation of a protein generates a variety of aggregates, all of which are likely to be toxic to some degree. A wide variety of biochemical, physiological and cytological perturbations has been identified following the exposure of cells and animals to such species, independently of their identity. The oligomers have also been reported to interact with a variety of molecular targets. Hence, it is unlikely that there is a unique mechanism of toxicity or a unique cascade of cellular events. The misfolded nature of protein aggregates causes a multitude of aberrant interactions with a multitude of cellular components, including membranes, protein receptors, soluble proteins, RNAs, small metabolites, etc.
Epithelia control the secretion of hormones into the circulatory system, as well as the secretion of sweat, mucus, enzymes, and other products that are delivered by ducts Epithelial membranes include the serous membrane (which lines body cavities), cutaneous membrane (i.e. the skin), and mucous membrane (which lines the interior of hollow organs). Other functions of epithelial cells include diffusion, filtration, secretion, selective absorption, and transcellular transport.
=== Cleaning of cork === Natural cork is a suberin based natural polymer foam that can have unpleasant substances which are responsible for the loss of quality in wine. The leading substance is 2,4,6 trichloroanisole (TCA), which can be detected at concentrations as low as 2 ng/l in the wine. Supercritical CO2 is used at industrial scale to remove this substance and guarantee that the wine retains its full quality.
In October 2014, Shankar announced the production of an unofficial spin-off online series based on the Dark Judges that would be released later that month. The animated miniseries was titled Judge Dredd: Superfiend and all its six episodes were released on 27 October 2014 on YouTube. In March 2015, Garland said that a direct sequel would likely not happen in the near future, at least not with the crew involved in the original film. In 2016, Urban said that "conversations are happening" regarding a Dredd continuation on streaming services Netflix or Amazon Prime. In an interview in May 2016, Urban said that while the film's "mishandled" marketing strategy and "unfortunate" box office performance meant that it was "problematic" to try to make a sequel, "the success it has achieved in all post-theatrical mediums has definitely strengthened the argument in favour of a sequel." In May 2017, a television series named Judge Dredd: Mega-City One was announced to be in development by IM Global Television and Rebellion. In August 2017, Urban stated he was in discussion to star in the series. The series was eventually put on hold due to the pandemic back in 2020. Rebellion CEO Jason Kingsley explained to Radio Times back in 2020, "I want there to be a sequel [to Dredd]. We've got the rights back so we can do it, we've just got to get rid of this virus thing that's going on at the moment, and then hopefully things can kick off in all sorts of different areas of making film and TV, it's just– it's all very messed up at the moment for everybody".
Sources: en.wikipedia.org
==== Agents, brokers, and commission merchants ==== These firms typically do not take title to goods. Instead, they earn a commission or fee for matching buyers and sellers, negotiating terms, or arranging logistics.
The types of entrees vary with the producer and the issued menu (of which there are usually 7 to 12), but the common set is based on a traditional Russian outdoorsmen fare, is largely formed out of the commercially available canned food, and usually includes 1 portion of stewed beef or pork, two meat-with-vegetables dishes, like various porridges, stews or canned fish, and one or two spreads, such as liver pâté, sausage stuffing or processed cheese. Desserts may include fruit jams, chocolate and/or walnut spreads, chocolate bars, sweetened condensed milk, etc., but baked goods are usually avoided out of concerns about their shelf life. Other variants may add canned speck and/or dried fish or exchange the hexamine tablets for the flameless heater.
To avoid the deep disagreements surrounding the theories of the essential features of well-being, some researchers examine components and contributing factors, independent of whether they are integral parts or external causes. For example, there is wide agreement that positive emotions, achievements, interpersonal relationships, and health typically contribute to well-being in some form, despite academic disagreement about their precise roles.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.